Drugs / Empagliflozin/Metformin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01811953 | Mar → May 2013 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Empagliflozin/Metformin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01811953 ↗ |
| Route | Oral | “fixed-dose-combination tablet, oral with 240 ml water under fasted conditions” NCT01811953 ↗ |